Le Lézard
Classified in: Health
Subject: Conference Calls/ Webcasts

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Corporate Update


BURNABY, British Columbia, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will report its second quarter 2022 financial and operating results after the close of U.S. financial markets on Tuesday, August 9, 2022.

Conference Call/Webcast Information:

Date:     Tuesday, August 9, 2022
Time:    4:30 pm Eastern Time (1:30 pm Pacific Time)
Dial-In Number: 1-800-715-9871
International Dial-In:        1-646-307-1963
Conference ID:   6560707

The webcast will also be broadcast live on the "Investors" section of Xenon's website at investor.xenon-pharma.com and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

"Xenon" and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: [email protected]



These press releases may also interest you

at 11:00
States with Highest COVID-19 Vaccination Rates Showed Steepest Decline in Pediatric Asthma Prevalence
States with high rates of COVID-19 vaccination saw more pediatric asthma patients get a break from their symptoms, according to new research published today in JAMA Network Open by leaders from Nemours Children's Health and Endeavor Health....

at 10:57
Terminix Announces National United Soccer League Ticket Giveaway
Terminix®, a Rentokil Terminix company, is thrilled to announce an exciting national ticket giveaway for fans of USL Championship and League One soccer. The "Terminix It for Tickets" sweepstakes aims to celebrate the passion of soccer fans across the...

at 10:55
Gynecology Collaboration and Licensing Agreements Analysis Report 2024 with Directory of Deals Signed by the World's Leading Life Science Companies Since 2016 - ResearchAndMarkets.com
The "Gynecology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Gynecology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gynecology...

at 10:50
Evive Brands Continues Q2 Steady Growth with 12 New Franchise Agreements
Evive Brands, a leader in the health and home services sector, today announced continued expansion in the second quarter of 2024, signing 12 new franchise agreements across its portfolio. The community of premier franchise brands includes Assisted...

at 10:45
Lung Health Foundation Appoints Donna Cansfield As New Chair of Board of Directors
The Lung Health Foundation (LHF) (lunghealth.ca), Canada's leading non-profit lung health organization, today announced new appointments to its Board of Directors, reinforcing its commitment to improving lung health for all Canadians. Donna Cansfield...

at 10:35
Appeal launched to support people impacted by Hurricane Beryl
The Canadian Red Cross has launched the Hurricane Beryl Appeal to help those affected by the hurricane. The Red Cross is working to help those impacted by Hurricane Beryl in the Caribbean region as quickly as possible. Money raised will enable the...

More news about Health...


News published on and distributed by: